| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.23 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 0.002 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 0.002 |